Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19) under the presumption that such plasma contains potentially therapeutic antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can be passively transferred to the plasma recipient. Dr. Michael Joyner discusses whether convalescent plasma with high antibody levels rather than low antibody levels is associated with a lower risk of death.

Image courtesy of Michael Joyner

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Should investors join the index revolution?

Next Article

Do patients get better? A review of outcomes from a crisis house and home treatment team partnership

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error: Faculti Content is protected. Please check our Privacy Policy and Terms and Conditions.

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×